By Months: Irja Lutsar

The speaker demonstrates expertise in the details of research and development funding, citing specific budget figures (80 million for the Ministry of Economic Affairs and Communications versus 1.48 million for the Ministry of Social Affairs). The role of clinical trials and their underfunding within the Ministry of Social Affairs budget is separately emphasized, demonstrating knowledge of the foundations of evidence-based treatment.

The speaker demonstrates strong expertise in the fields of crisis resolution (civil crisis) and medicine, claiming to have recently observed civil crisis management firsthand. They utilize specific knowledge, referencing the nature of medicine as an empirical discipline and the lengthy timelines required to obtain research permits (a year and a half). Furthermore, they are well-versed in the impact of data protection regulations on scientific research both in Estonia and across the wider European Union.

The speaker possesses deep expertise in the fields of medicine and healthcare, particularly concerning intensive care, end-of-life care, and infectious diseases (HIV). They utilize technical terminology (PET, positron emission tomography) and draw upon personal experience, having worked as a pediatrician and conducted studies at Tartu Prison. Furthermore, they demonstrate awareness regarding issues in legal education and the structure of healthcare provision within correctional facilities.

The speaker demonstrates expertise regarding the levels of the education system—basic, secondary (gymnasium), and higher education—as well as international study tracks. They employ a data-driven approach, noting the poor quality of the data, and validated their knowledge using artificial intelligence, which suggests strong technical awareness.

High level of expertise in the fields of medicine, pharmacy, and social policy, citing over 45 years of personal medical experience. Uses precise terminology (ethics committee, hospital exemption, palliative care) and demonstrates deep knowledge of the specifics of legislative amendments and committee deliberations. Is also aware of European Union directives and their transposition procedures.

The speaker demonstrates profound expertise in the fields of public health, pharmaceuticals, and scientific regulation, utilizing technical terminology (e.g., mRNA technology, validated laboratory tests). They support their arguments with specific data, referencing statistics from the Estonian State Agency of Medicines regarding adverse effects (0.2–0.3%) and the 2023 Nobel Prize. They emphasize the importance of scientific competence and the authority of the European Medicines Agency (EMA).

The speaker demonstrates profound expertise in the field of science and research management, identifying themselves as a former scientist. Specific terminology is employed, such as "grants," "uncertainty," and "data cross-utilization," which points to their authority on issues of science policy and data infrastructure. Particular emphasis is placed on the necessity of data preservation, analysis, and aggregation.

The speaker demonstrates profound expertise in medicine and the organization of healthcare systems, citing their specific field (medical science) and employing specialized terminology (consolidation, anesthesia services, depreciation/amortization). They emphasize the functional planning of services, for instance, highlighting the necessity of co-locating maternity care and surgical care, and referencing the development concept of the Tartu University Hospital. However, they acknowledge their lack of expertise in the construction sector.